Basic Information
Papyrus Therapeutics is an emerging biopharmaceutical company dedicated to developing novel therapies based on tumor suppression. Papyrus' lead therapeutic is a modified recombinant version of opioid-binding protein/cell adhesion molecule-like (OPCML).
Papyrus Therapeutics, Inc.
Pennsylvania,United States of America
unclear
--
pblake@pytxi.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios